Barclays’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
Barclays's ATRC Position: Q3 2026 in Review
Barclays increased its AtriCure (ATRC) stake by 31% in Q3 2026, buying an estimated $387K and bringing the position to 36,172 shares worth $2.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2577.
Barclays first reported a position in ATRC in Q2 2013 and has held it in 54 quarters since. The position peaked at $7.44M in Q1 2020. 286 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.
- Barclays held 36,172 shares of AtriCure worth $2.03M as of Q3 2026.
- Barclays bought 8,590 AtriCure shares in Q3 2026, an estimated $387K.
- AtriCure made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #2577 holding.
- Barclays first reported a position in AtriCure in Q2 2013 and has held it in 54 quarters since.
- Barclays's AtriCure position peaked at $7.44M in Q1 2020.
- 286 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.